Evidence map›Paper›PMID 28512429›Full record

ArticleFrontiers in aging neuroscience2017

Reduced Prefrontal Short-Latency Afferent Inhibition in Older Adults and Its Relation to Executive Function: A TMS-EEG Study.

Yoshihiro Noda, Reza Zomorrodi, Felicity Backhouse, Robin F H Cash, Mera S Barr, Tarek K Rajji, Robert Chen, Zafiris J Daskalakis, Daniel M Blumberger

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023
    Trial
  3. Clinical utility and prospective of TMS-EEG: Updated review from an international expert group.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yoshihiro NodaTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Reza ZomorrodiTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Felicity BackhouseTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Robin F H CashDivision of Neurology, Division of Brain, Imaging and Behaviour - Systems Neuroscience, Department of Medicine, Krembil Research Institute, University Health Network, University of TorontoToronto, ON, Canada.
Mera S BarrTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Tarek K RajjiTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Robert ChenDivision of Neurology, Division of Brain, Imaging and Behaviour - Systems Neuroscience, Department of Medicine, Krembil Research Institute, University Health Network, University of TorontoToronto, ON, Canada.
Zafiris J DaskalakisTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Daniel M BlumbergerTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada.
Centre for Addiction and Mental Health · CAUniversity of Toronto · CAKrembil Research InstituteUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combining transcranial magnetic stimulation (TMS) with electroencephalography (EEG) allows for the assessment of various neurophysiological processes in the human cortex. One of these paradigms, short-latency afferent inhibition (SAI), is thought to be a sensitive measure of cholinergic activity. In a previous study, we demonstrated the temporal pattern of this paradigm from both the motor (M1) and dorsolateral prefrontal cortex (DLPFC) using simultaneous TMS-EEG recording. The SAI paradigm led to marked modulations at N100. In this study, we aimed to investigate the age-related effects on TMS-evoked potentials (TEPs) with the SAI from M1 and the DLPFC in younger (18-59 years old) and older (≥60 years old) participants. Older participants showed significantly lower N100 modulation in M1-SAI as well as DLPFC-SAI compared to the younger participants. Furthermore, the modulation of N100 by DLPFC-SAI in the older participants correlated with executive function as measured with the Trail making test. This paradigm has the potential to non-invasively identify cholinergic changes in cortical regions related to cognition in older participants.

Indexed as

age-related changescognitiondorsolateral prefrontal cortexshort-latency afferent inhibitionTMS-EEG

Identifiers

PMID28512429
PMCPMC5411436
OpenAlexW2610335137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.